A Pilot Study to Enhance F18 FDG-PET Imaging of Prostate Cancers With the Metabolic Inhibitor Ranolazine

Clinical trial NCT01992016 · COMPLETED

Trial details

NCT number: NCT01992016
Sponsor: University of Colorado, Denver
Status: COMPLETED
Phase: Not Applicable
Study type: INTERVENTIONAL

Adenocarcinoma of the Prostate Bone Metastases Soft Tissue Metastases Stage IIA Prostate Cancer Stage IIB Prostate Cancer Stage III Prostate Cancer Stage IV Prostate Cancer

Start date: 2014-04-07
Primary completion: 2016-10-08
Enrollment: 11

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.